RAD51D-related cancer predisposition

MONDO:0700274

Hereditary cancer predisposition due to variation(s) in the RAD51D gene. Pathogenic germline variation in RAD51D confers an autosomal dominant predisposition to tumor formation at multiple primary sites, including ovarian cancer, triple negative breast cancer and ER negative breast cancer.

36 clinical trials for this condition and its sub-types, 4 tagged with RAD51D-related cancer predisposition itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →
Sort by